Antigen Processing And Presentation In The Intestine

抗原在肠道中的加工和呈现

基本信息

项目摘要

This project focuses on how antigens are processed in the intestine of mice. While it is clear that the outcome of oral antigen exposure can be either positive, i.e., the development of mucosal IgA responses, and in some cases the induction of systemic immunity as well, or negative, i.e., the induction of oral tolerance, the details of why one or the other outcome occurs is complex and poorly understood. While it is known that the antigen formulation, the presence of adjuvants, and the antigen dose, as well as genetic factors, can affect mucosal immune responses, how these act to influence immunity has never been established. In prior studies we have established the presence of different antigen-presenting cell populations in the Peyer's patch (PP) and lamina propria and have detailed the surface phenotype, function, and migration of DCs in the PP using in situ immunofluorecense microscopy and in situ hybridization, flow cytometry of purified cells, and in vitro assays of cytokine production (ELISA and quantitative RT-PCR) and T cell differentiation. We determined that there are 3 separate subpopulations of immature DCs in the PP, lymphoid (CD8+), myeloid (CD11b+), and double negative (DN) Dcs that express neither CD8 or CD11b. These separated DC subpopulations are located in distinct sites in the PP, and are capable of inducing the differentiaion of T cells into cells that produce unique cytokine profiles. Most importantly, we demonstrated that PP DCs have the unique capacity to induce the differntiation of T cells that produce high levels of IL-10, a cytokine important for the IgA B cell differentiation. These studies thus are some of the first to directly demonstrate that DCs from different tissues may be unique in their ability to induce tissue specific immunity. Over the past year we have initiated studies on the role of these DC subsets in models of inflammatory bowel disease and in murine infection with reovirus, a model intestinal virus infection. We found that DN DCs in the subepithelial dome region of the PP process viral antigen from virally infected apoptotic epithelial cells.
这个项目的重点是研究抗原在小鼠肠道中的加工过程。虽然很明显,口腔抗原暴露的结果可能是阳性的,即粘膜IgA反应的发展,在某些情况下也会诱导全身免疫,或者是阴性的,即诱导口服耐受,但为什么会发生这种或那种结果的细节是复杂的,而且知之甚少。虽然已知抗原制剂、佐剂的存在、抗原剂量以及遗传因素可以影响粘膜免疫反应,但这些因素如何影响免疫却从未确定过。在之前的研究中,我们已经在Peyer’s patch (PP)和固有层中建立了不同抗原呈递细胞群的存在,并使用原位免疫荧光显微镜和原位杂交,纯化细胞的流式细胞术,以及细胞因子产生(ELISA和定量RT-PCR)和T细胞分化的体外测定,详细描述了PP中dc的表面表型,功能和迁移。我们确定在PP中存在3个独立的未成熟dc亚群,淋巴(CD8+)、髓系(CD11b+)和双阴性(DN) dc,它们既不表达CD8也不表达CD11b。这些分离的DC亚群位于PP的不同位置,能够诱导T细胞分化为产生独特细胞因子谱的细胞。最重要的是,我们证明了PP dc具有诱导T细胞分化的独特能力,可以产生高水平的IL-10, IL-10是一种对IgA B细胞分化很重要的细胞因子。因此,这些研究是第一批直接证明来自不同组织的树突状细胞在诱导组织特异性免疫的能力方面可能是独特的。在过去的一年里,我们已经开始研究这些DC亚群在炎症性肠病模型和呼肠孤病毒(一种肠道病毒感染模型)感染小鼠中的作用。我们发现在PP的上皮下穹丘区域的DN dc处理来自病毒感染的凋亡上皮细胞的病毒抗原。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BRIAN KELSALL其他文献

BRIAN KELSALL的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BRIAN KELSALL', 18)}}的其他基金

DEVELOPMENT OF NOVEL MUCOSAL VACCINE STRATEGIES
新型粘膜疫苗策略的开发
  • 批准号:
    6289007
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
REGULATION OF IL 12 PRODUCTION BY BETA 2 INTEGRINS
Beta 2 整合素对 IL 12 产生的调节
  • 批准号:
    6288991
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
MECHANISMS OF ORAL TOLERANCE
口服耐受的机制
  • 批准号:
    6288958
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
ANTIGEN PROCESSING AND PRESENTATION IN THE INTESTINE
抗原在肠道中的加工和呈递
  • 批准号:
    6289008
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Regulation Of IL-12 Production
IL-12 生产的监管
  • 批准号:
    6986453
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Antigen Processing And Presentation In The Intestine
抗原在肠道中的加工和呈现
  • 批准号:
    6669741
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
REGULATION OF IL 12 PRODUCTION
IL 12 生产的监管
  • 批准号:
    6431689
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Antigen Processing And Presentation In The Intestine
抗原在肠道中的加工和呈现
  • 批准号:
    6521434
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Antigen Processing And Presentation In The Intestine
抗原在肠道中的加工和呈现
  • 批准号:
    7964413
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:
Antigen Processing And Presentation In The Intestine
抗原在肠道中的加工和呈现
  • 批准号:
    8555836
  • 财政年份:
  • 资助金额:
    --
  • 项目类别:

相似海外基金

MHC Class II Antigen Presentation In Melanoma: Impact on Immune Recognition
黑色素瘤中 MHC II 类抗原的呈现:对免疫识别的影响
  • 批准号:
    10674177
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
MHC class II antigen presentation in melanoma: impact on immune recognition
黑色素瘤中 MHC II 类抗原呈递:对免疫识别的影响
  • 批准号:
    10618790
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
MHC class II antigen presentation in melanoma: impact on immune recognition
黑色素瘤中 MHC II 类抗原呈递:对免疫识别的影响
  • 批准号:
    10392325
  • 财政年份:
    2021
  • 资助金额:
    --
  • 项目类别:
VARIATION IN MHC CLASS II ANTIGEN BINDING SITE OF ATLANTIC SALMON, SALMO SALAR
大西洋鲑鱼 SALMO SALAR MHC II 类抗原结合位点的变异
  • 批准号:
    8360306
  • 财政年份:
    2011
  • 资助金额:
    --
  • 项目类别:
VARIATION IN MHC CLASS II ANTIGEN BINDING SITE OF ATLANTIC SALMON, SALMO SALAR
大西洋鲑鱼 SALMO SALAR MHC II 类抗原结合位点的变异
  • 批准号:
    8167705
  • 财政年份:
    2010
  • 资助金额:
    --
  • 项目类别:
MHC Class II Antigen Processing and Immune Recognition of Melanoma
MHC II 类抗原加工和黑色素瘤的免疫识别
  • 批准号:
    8131116
  • 财政年份:
    2007
  • 资助金额:
    --
  • 项目类别:
MHC Class II Antigen Processing and Immune Recognition of Melanoma
MHC II 类抗原加工和黑色素瘤的免疫识别
  • 批准号:
    7321929
  • 财政年份:
    2007
  • 资助金额:
    --
  • 项目类别:
MHC Class II Antigen Processing and Immune Recognition of Melanoma
MHC II 类抗原加工和黑色素瘤的免疫识别
  • 批准号:
    7673392
  • 财政年份:
    2007
  • 资助金额:
    --
  • 项目类别:
MHC Class II Antigen Processing and Immune Recognition of Melanoma
MHC II 类抗原加工和黑色素瘤的免疫识别
  • 批准号:
    7483748
  • 财政年份:
    2007
  • 资助金额:
    --
  • 项目类别:
MHC Class II Antigen Processing and Immune Recognition of Melanoma
MHC II 类抗原加工和黑色素瘤的免疫识别
  • 批准号:
    7907767
  • 财政年份:
    2007
  • 资助金额:
    --
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了